Immuneering annual operating margin
2020
2021
2022
Immuneering Operating Margin Growth & History (IMRX)
Immuneering's operating margin was −16,325.77% for fiscal 2022.
View full Immuneering company overviewImmuneering annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −16,325.77% | −14696.61 pp |
| 2021 | 2021-12-31 | −1,629.17% | −890.16 pp |
| 2020 | 2020-12-31 | −739.01% | — |
Immuneering quarterly operating margin
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −3,073,627.91% | −3067764.89 pp |
| Q3 2022 | 2022-09-30 | −34,362.04% | −32590.03 pp |
| Q2 2022 | 2022-06-30 | −12,334.43% | −11123.76 pp |
| Q1 2022 | 2022-03-31 | −7,036.37% | −6202.90 pp |
| Q4 2021 | 2021-12-31 | −5,863.02% | −5218.36 pp |
| Q3 2021 | 2021-09-30 | −1,772.01% | −1021.93 pp |
| Q2 2021 | 2021-06-30 | −1,210.67% | — |
| Q1 2021 | 2021-03-31 | −833.47% | — |
| Q3 2020 | 2020-09-30 | −644.66% | — |
| Q2 2020 | 2020-06-30 | −750.08% | — |
Immuneering operating margin trends
Across the available reported history, Immuneering's operating margin decreased from −1,629.17% to −16,325.77%, a change of −14696.61 percentage points. The latest reported quarter, Q4 2022, shows −3,073,627.91%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immuneering filings at SEC.gov ↗